AMPH (NASDAQ) - Amphastar P

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03209R1032
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API). It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock. Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for AMPH (NASDAQ) - Amphastar P
  • Uncommon Growth Rate


Market Cap in USD 2,311m
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 2014-06-25


Fundamental 4.50
Dividend -
Performance 5y 6.27
Rel. Performance vs Sector 1.84
Analysts 4.25
Fair Price Total Ret. 45.43
Fair Price DCF todo


Growth TTM 56.80%
CAGR 5y 19.08%
CAGR / Mean Drawdown 5y 1.01
Sharpe Ratio TTM 1.21
Alpha vs SP500 TTM 42.78
Beta vs SP500 5y weekly 0.71
CAPM 6.90%
Average Daily Range 2m 3.96%
Reversal Oscillator 18.53
Volatility GJR Garch 1y 39.58%
Price / SMA 50 -14.42%
Price / SMA 200 7.23%
Current Volume 501.3k
Average Volume 20d 641.4k


Yield TTM 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Consistency of Dividends all time 0.0%